Warfarin Patient Self-management Implementation in the US Healthcare System

Description

In the US, patients receiving warfarin therapy are rarely allowed to engage in patient self-management (PSM) which is less burdensome, less expensive, and safer than standard clinic-directed warfarin management. The long-term objective of our application is to improve the safety of ambulatory warfarin therapy through increasing the implementation of PSM.

Conditions

Atrial Fibrillation, Venous Thromboembolism, Heart Valve Diseases

Study Overview

Study Details

Study overview

In the US, patients receiving warfarin therapy are rarely allowed to engage in patient self-management (PSM) which is less burdensome, less expensive, and safer than standard clinic-directed warfarin management. The long-term objective of our application is to improve the safety of ambulatory warfarin therapy through increasing the implementation of PSM.

Overcoming Barriers to Warfarin Patient Self-management Implementation in the US Healthcare System

Warfarin Patient Self-management Implementation in the US Healthcare System

Condition
Atrial Fibrillation
Intervention / Treatment

-

Contacts and Locations

Loma Linda

VA Loma Linda Healthcare System, Loma Linda, California, United States, 92357

Boston

Brigham and Women's Hospital, Boston, Massachusetts, United States, 02115

Ann Arbor

University of Michigan, Ann Arbor, Michigan, United States, 48109

Salt Lake City

University of Utah Thrombosis Center, Salt Lake City, Utah, United States, 84112

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * At least 18 years of age treated with warfarin for any indication for at least 9 months prior to enrollment
  • * Demonstrate the willingness and ability to test their own INR using a home INR monitoring device or have same-day access to clinic-derived INR results (e.g., via electronic medical record secure messaging)
  • * Willing to make independent decisions about warfarin dosing based on INR results
  • * Able to perform INR tests at least every 2 weeks
  • * Currently have and willing to maintain internet access for the duration of the study in order to complete online data collection forms
  • * Have an anticipated duration of warfarin therapy of at least 6 months
  • * Goal INR range other than 2.0-3.0 or 2.5-3.5
  • * Known poor adherence to warfarin therapy
  • * Non-English speaking
  • * Inability or refusal to provide written informed consent

Ages Eligible for Study

18 Years to

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

University of Utah,

Study Record Dates

2025-04-30